Lung Cancer Research & Clinical Trials
Through a special alliance with USC Norris Comprehensive Cancer Center,
Hoag Family Cancer Institute is able to provide Orange County residents
access to clinical trials only found in academic institutions.
Hoag and USC Norris are currently offering the following Phase 1 Clinical
Trial for Advanced Non-Small Cell Lung Cancer patients. A Phase 1 Clinical
Trial is a trial that is new to the market. When laboratory testing shows
that a new treatment may help treat cancer, Phase 1 trials are then completed
to find out how much of the drug is safe to administer, determine the
side effects, and the efficiency of the treatment.
We encourage patients to review the requirements for the trial, and contact
Hoag with any questions at 949-764-5543.
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens
in Treating Patients With Advanced or Metastatic Solid Tumors (Phase 1 Clinical Trial, Appropriate for patients with advanced pancreatic,
gallbladder, biliary, head and neck, and non-small cell lung cancer.)
A Phase 1a/1b Study of FPA008 in Combination with Nivolumab in Patients
with Selected Advanced Cancers (Phase 1 Clinical Trial, Appropriate for patients with advanced renal,
head and neck, and non-small cell lung cancer.)
Phase 1, Multiple Ascending Dose Study Of Anti-HER2 FCAB™ FS102 In
HER2 Positive Solid Tumors (Phase 1 Clinical Trial, Appropriate for patients with advanced HER2 positive
cancers: bladder, salivary gland, endometrial, pancreatic, non-small-cell
lung cancer (NSCLC), gastric, colon & esophageal.)
With questions, please contact Hoag's Clinical Trials department at
Multidisciplinary Lung Cancer Case Conferences
Hoag’s multidisciplinary Lung Cancer Case Conferences provide collaborative
care planning for lung cancer patients. The weekly Lung Cancer Case Conference
brings together all of a patient’s physicians for a multidisciplinary
approach to treatment planning. All aspects of a patient’s care
are discussed by a team of lung cancer specialists, including thoracic
surgeons, medical oncologists, radiation oncologists, pulmonologists,
radiologists, pathologists, nurses and support staff.
Experience You Can Trust!
Hoag Lung Cancer Program’s commitment to accurate diagnosis, combined
with progressive therapeutic options enables Hoag patients to achieve
some of the highest clinical outcomes in the nation.
To learn more about Hoag's top rated Lung Cancer Program, visit:
For more about Hoag Lung Cancer Program, or to schedule a second-opinion
consultation with a Hoag lung cancer expert, please call